GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
164 hedge funds and large institutions have $2.2B invested in GW Pharmaceuticals Plc American Depositary Shares in 2016 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 53 increasing their positions, 33 reducing their positions, and 24 closing their positions.
117% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 24
61% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 33
19% more funds holding
Funds holding: 138 → 164 (+26)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
9% less call options, than puts
Call options by funds: $199M | Put options by funds: $218M
8% less capital invested
Capital invested by funds: $2.41B → $2.2B (-$205M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PP
Prudential plc
London, England,
United Kingdom
|
+$106M |
| 2 |
O
OrbiMed
New York
|
+$43.4M |
| 3 |
SCM
Scopia Capital Management
New York
|
+$24M |
| 4 |
Goldman Sachs
New York
|
+$18.8M |
| 5 |
Capital Fund Management (CFM)
Paris,
France
|
+$17.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
-$36.8M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$21.6M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$19.1M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$17.7M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$15M |
GWPH Hedge Fund Activity: Q4 2016 in Review
164 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q4 2016, worth a combined $2.2B — down 8.5% from $2.41B a quarter earlier.
Buyers outnumbered sellers: 52 funds opened new GWPH positions and 24 closed out — a net gain of 28 holders — while 53 added to existing stakes and 33 trimmed.
The largest buyer was Prudential plc, adding an estimated $106M. The largest seller was Bank of New York Mellon, cutting an estimated $36.8M.
- 164 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q4 2016, up from 138 in Q3 2016.
- Funds reported $2.2B of GW Pharmaceuticals Plc American Depositary Shares stock for Q4 2016, down 8.5% quarter-over-quarter.
- 52 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q4 2016 and 24 closed out, a net change of +28 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q4 2016 was Prudential plc, an estimated $106M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q4 2016 was Bank of New York Mellon, an estimated $36.8M sold.
Based on aggregated 13F filings for Q4 2016.